tetano
Editor, Senior Moderator
PLoS One
. 2024 Dec 26;19(12):e0309305.
doi: 10.1371/journal.pone.0309305. eCollection 2024. A cell-based Papain-like Protease (PLpro) activity assay for rapid detection of active SARS-CoV-2 infections and antivirals
Anahi G Jimenez-Campos[SUP] 1 [/SUP], Lucas I Maestas[SUP] 1 [/SUP], Nileena Velappan[SUP] 2 [/SUP], Brian Beck[SUP] 3 [/SUP], Chunyan Ye[SUP] 4 [/SUP], Keith Wernsing[SUP] 5 [/SUP], Yaniksa Mata-Solis[SUP] 5 [/SUP], William J Bruno[SUP] 6 [/SUP], Silas C Bussmann[SUP] 1 [/SUP], Steven Bradfute[SUP] 4 [/SUP], Justin T Baca[SUP] 1 [/SUP], Frauke H Rininsland[SUP] 5 [/SUP]
Affiliations
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants are a continuous threat to human life. An urgent need remains for simple and fast tests that reliably detect active infections with SARS-CoV-2 and its variants in the early stage of infection. Here we introduce a simple and rapid activity-based diagnostic (ABDx) test that identifies SARS-CoV-2 infections by measuring the activity of a viral enzyme, Papain-Like protease (PLpro). The test system consists of a peptide that fluoresces when cleaved by SARS PLpro that is active in crude, unprocessed lysates from human tongue scrapes and saliva. Test results are obtained in 30 minutes or less using widely available fluorescence plate readers, or a battery-operated portable instrument for on-site testing. Proof-of-concept was obtained in a study on clinical specimens collected from patients with COVID-19 like symptoms who tested positive (n = 10) or negative (n = 10) with LIAT RT-PCR using nasal mid turbinate swabs. When saliva from these patients was tested with in-house endpoint RT-PCR, 17 were positive and only 5 specimens were negative, of which 2 became positive when tested 5 days later. PLpro activity correlated in 17 of these cases (3 out of 3 negatives and 14 out of 16 positives, with one invalid specimen). Despite the small number of samples, the agreement was significant (p value = 0.01). Two false negatives were detected, one from a sample with a late Ct value of 35 in diagnostic RT-PCR, indicating that an active infection was no longer present. The PLpro assay is easily scalable and expected to detect all viable SARS-CoV-2 variants, making it attractive as a screening and surveillance tool. Additionally, we show feasibility of the platform as a new homogeneous phenotypic assay for rapid screening of SARS-CoV-2 antiviral drugs and neutralizing antibodies.
. 2024 Dec 26;19(12):e0309305.
doi: 10.1371/journal.pone.0309305. eCollection 2024. A cell-based Papain-like Protease (PLpro) activity assay for rapid detection of active SARS-CoV-2 infections and antivirals
Anahi G Jimenez-Campos[SUP] 1 [/SUP], Lucas I Maestas[SUP] 1 [/SUP], Nileena Velappan[SUP] 2 [/SUP], Brian Beck[SUP] 3 [/SUP], Chunyan Ye[SUP] 4 [/SUP], Keith Wernsing[SUP] 5 [/SUP], Yaniksa Mata-Solis[SUP] 5 [/SUP], William J Bruno[SUP] 6 [/SUP], Silas C Bussmann[SUP] 1 [/SUP], Steven Bradfute[SUP] 4 [/SUP], Justin T Baca[SUP] 1 [/SUP], Frauke H Rininsland[SUP] 5 [/SUP]
Affiliations
- PMID: 39724215
- DOI: 10.1371/journal.pone.0309305
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants are a continuous threat to human life. An urgent need remains for simple and fast tests that reliably detect active infections with SARS-CoV-2 and its variants in the early stage of infection. Here we introduce a simple and rapid activity-based diagnostic (ABDx) test that identifies SARS-CoV-2 infections by measuring the activity of a viral enzyme, Papain-Like protease (PLpro). The test system consists of a peptide that fluoresces when cleaved by SARS PLpro that is active in crude, unprocessed lysates from human tongue scrapes and saliva. Test results are obtained in 30 minutes or less using widely available fluorescence plate readers, or a battery-operated portable instrument for on-site testing. Proof-of-concept was obtained in a study on clinical specimens collected from patients with COVID-19 like symptoms who tested positive (n = 10) or negative (n = 10) with LIAT RT-PCR using nasal mid turbinate swabs. When saliva from these patients was tested with in-house endpoint RT-PCR, 17 were positive and only 5 specimens were negative, of which 2 became positive when tested 5 days later. PLpro activity correlated in 17 of these cases (3 out of 3 negatives and 14 out of 16 positives, with one invalid specimen). Despite the small number of samples, the agreement was significant (p value = 0.01). Two false negatives were detected, one from a sample with a late Ct value of 35 in diagnostic RT-PCR, indicating that an active infection was no longer present. The PLpro assay is easily scalable and expected to detect all viable SARS-CoV-2 variants, making it attractive as a screening and surveillance tool. Additionally, we show feasibility of the platform as a new homogeneous phenotypic assay for rapid screening of SARS-CoV-2 antiviral drugs and neutralizing antibodies.